Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, P. R. China.
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, P. R. China.
J Cardiothorac Surg. 2023 Jun 20;18(1):195. doi: 10.1186/s13019-023-02288-0.
Lung cancer is the second most commonly diagnosed cancer and ranks the first in mortality. Pathological lymph node status(pN) of lung cancer affects the treatment strategy after surgery while systematic lymph node dissection(SLND) is always unsatisfied.
We reviewed the clinicopathological features of 2,696 patients with LUAD and one single lesion ≤ 5 cm who underwent SLND in addition to lung resection at the Sun Yat-Sen University Cancer Center. The relationship between the pN status and all other clinicopathological features was assessed. All participants were stochastically divided into development and validation cohorts; the former was used to establish a logistic regression model based on selected factors from stepwise backward algorithm to predict pN status. C-statistics, accuracy, sensitivity, and specificity were calculated for both cohorts to test the model performance.
Nerve tract infiltration (NTI), visceral pleural infiltration (PI), lymphovascular infiltration (LVI), right upper lobe (RUL), low differentiated component, tumor size, micropapillary component, lepidic component, and micropapillary predominance were included in the final model. Model performance in the development and validation cohorts was as follows: 0.861 (95% CI: 0.842-0.883) and 0.840 (95% CI: 0.804-0.876) for the C-statistics and 0.803 (95% CI: 0.784-0.821) and 0.785 (95% CI: 0.755-0.814) for accuracy, and 0.754 (95% CI: 0.706-0.798) and 0.686 (95% CI: 0.607-0.757) for sensitivity and 0.814 (95% CI: 0.794-0.833) and 0.811 (95% CI: 0.778-0.841) for specificity, respectively.
Our study showed an easy and credible tool with good performance in predicting pN in patients with LUAD with a single tumor ≤ 5.0 cm without SLND and it is valuable to adjust the treatment strategy.
肺癌是第二大常见癌症,也是死亡率最高的癌症。肺癌的病理淋巴结状态(pN)影响手术后的治疗策略,而系统性淋巴结清扫术(SLND)一直不能令人满意。
我们回顾了中山大学肿瘤防治中心 2696 例接受 SLND 加肺切除术的 LUAD 患者和单一病灶≤5cm 的临床病理特征。评估了 pN 状态与所有其他临床病理特征的关系。所有参与者被随机分为开发和验证队列;前者用于基于逐步后退算法选择的因素建立基于逻辑回归的预测 pN 状态的模型。计算两个队列的 C 统计量、准确性、敏感性和特异性,以测试模型性能。
神经束浸润(NTI)、内脏胸膜浸润(PI)、淋巴血管浸润(LVI)、右上叶(RUL)、低分化成分、肿瘤大小、微乳头状成分、贴壁成分和微乳头状优势进入最终模型。在开发和验证队列中的模型性能如下:C 统计量为 0.861(95%CI:0.842-0.883)和 0.840(95%CI:0.804-0.876),准确性为 0.803(95%CI:0.784-0.821)和 0.785(95%CI:0.755-0.814),敏感性为 0.754(95%CI:0.706-0.798)和 0.686(95%CI:0.607-0.757),特异性为 0.814(95%CI:0.794-0.833)和 0.811(95%CI:0.778-0.841)。
我们的研究显示,对于未经 SLND 治疗的单一肿瘤≤5.0cm 的 LUAD 患者,预测 pN 具有良好性能的简单而可靠的工具,这对于调整治疗策略具有重要价值。